Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Solid Biosciences (SLDB) Non Operating Income: 2016-2024

Historic Non Operating Income for Solid Biosciences (SLDB) over the last 9 years, with Dec 2024 value amounting to $5.0 million.

  • Solid Biosciences' Non Operating Income fell 240.02% to -$2.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.0 million, marking a year-over-year decrease of 38.92%. This contributed to the annual value of $5.0 million for FY2024, which is 38.92% down from last year.
  • According to the latest figures from FY2024, Solid Biosciences' Non Operating Income is $5.0 million, which was down 38.92% from $8.2 million recorded in FY2023.
  • Solid Biosciences' 5-year Non Operating Income high stood at $20.5 million for FY2022, and its period low was $66,000 during FY2021.
  • Its 3-year average for Non Operating Income is $11.2 million, with a median of $8.2 million in 2023.
  • In the last 5 years, Solid Biosciences' Non Operating Income plummeted by 94.46% in 2020 and then soared by 30,916.67% in 2022.
  • Solid Biosciences' Non Operating Income (Yearly) stood at $116,000 in 2020, then crashed by 43.10% to $66,000 in 2021, then soared by 30,916.67% to $20.5 million in 2022, then tumbled by 59.76% to $8.2 million in 2023, then plummeted by 38.92% to $5.0 million in 2024.